In this study, LTP was used to inhibit lung cancer cells via the VEGF/VEGFR2/RAS/ERK axis, which provides a new direction for radiotherapy to inhibit the growth of lung cancer cells. The gene discussed is KDR; the disease is lung carcinoma.